Sex without fear – ​my experiment with ​the HIV-prevention drug PrEP

The Guardian, Thursday 22 June 2017 

When I first heard about the HIV-prevention drug PrEP – pre-exposure prophylaxis – I had mixed feelings.  It remains controversial even among readers of the gay magazine Attitude. “Why should my taxes pay for these sluts to have bareback sex?” is a typical comment. But I was worried that my reaction was the result of anti-gay conditioning, being brought up to think that I didn’t deserve the same rights as the rest of society, and I wanted to challenge this by taking the drug for three months to find out more.

 

VAC responds to PrEP-X Victoria Seroconversion

22 May 2017

VAC has learned that a person on the Victorian PrEPX study has seroconverted and become HIV positive. There are two ways that this may have occurred.

• If a person is not adherent to their PrEP regimen (taking the prescribed dose regularly) it is possible that they would not be protected against acquiring HIV;
• If a person comes into contact with a person living with HIV who has detectable viral load together with a strain of the virus that is resistant to PrEP medication it is possible (although extremely rare) that they might acquire that viral strain of HIV.

“Currently there are over 100,000 individuals who are taking PrEP globally as a way to protect themselves against HIV acquisition. To date there have been no confirmed cases in Australia of a person on PrEP being infected with a drug-resistant HIV,” commented VAC CEO, Simon Ruth.

Upcoming free community forum: PrEP_SA_NOW!

SAMESH,  April 2017

There has been a lot of community interest in the PrEPX-SA trial. You are invited to an upcoming community forum where a distinguished panel of experts and community members involved in the field will discuss PrEP, a powerful new tool to prevent HIV and the upcoming PrEPX-SA study.

The panel will include:

  • Associate Professor Edwina Wright (Alfred Health)
  • Professor Steve Wesselingh (SAHMRI)
  • Dr Charlotte Bell (Clinic 275)
  • Community membersWHEN: THURSDAY APRIL 27 6 PM – 7.30 PM

    WHERE: 57 HYDE STREET

    FREE – RSVP via email here

 

Antiretroviral sex: the transformation of safe sex?

February 2017

This free, public lecture, given by Associate Professor Martin Holt of the UNSW Centre for Social Research in Health, considers the radical shifts in HIV prevention associated with the use of HIV treatment and pre-exposure prophylaxis (PrEP).

These prevention strategies provide new ways to safely avoid HIV, but also pose challenges to the ways communities understand, and potentially practice, ‘safe sex’. As safe sex transforms to accommodate the new possibilities provided by ‘antiretroviral sex’, what are the effects on sexual and social relations, identities and HIV-related stigma?

These prevention strategies provide new ways to safely avoid HIV, but also pose challenges to the ways communities understand, and potentially practice, ‘safe sex’. As safe sex transforms to accommodate the new possibilities provided by ‘antiretroviral sex’, what are the effects on sexual and social relations, identities and HIV-related stigma?

With n treatintroduction by The Hon Michael Kirby AC CMG, and moderated by Dr Bridget Haire, AFAO President. The “Sex Lecture” is part of the 2017 Sydney Gay and Lesbian Mardi Gras Festival.

  • Watch video (57 minutes) below

Breaking news: SA announces HIV prevention drug trial

Jay Weatherill MP, Nat Cook MP, Wednesday, November 29, 2016

South Australians at high risk of contracting HIV will have access to the latest preventative technology study, as part of a State Government commitment announced today.

Pre-exposure prophylaxis or PrEP is the latest prevention therapy in the fight against HIV. Under a PrEP access trial, eligible South Australians who don’t have HIV and who are at high risk of acquiring HIV may be prescribed a daily oral pill which, when taken consistently, has been shown to be effective in preventing HIV.

South Australia will commence negotiations with other states currently leading PrEP access trials.

Read more hiv-prevention-drug-trial

 

 

 

Greens push for drug trial to reduce HIV risks in South Australia a ‘no brainer’

ABC News, 24/11/16

The Greens want South Australia to be part of a trial for a pill which can reduce the risk of HIV infection and is already being widely used overseas.

The drug called PrEP — short for pre exposure prophylaxis — is made up of antiretroviral drugs taken by HIV-negative people to prevent HIV infection, according to the ACON website, which is primarily funded by the NSW Ministry of Health.

Read more here